In recent months, Washington, Colorado, and Nevada, have enacted public option-style laws aimed at containing costs and increasing access to health insurance coverage. In a new post for the Commonwealth Fund, CHIR experts Christine Monahan, Kevin Lucia, and Justin Giovannelli examine these efforts and their implications for federal and state policymakers.
As Congress considers a variety of proposals to address prescription drug prices, there is a growing trend of states capping the out of pocket costs for insulin. CHIR’s Megan Houston considers the impact of insulin copay caps and how states are limited in their efforts to tackle prescription drug prices.
The Biden administration has issued the first in a series of rules to implement the No Surprises Act, a sweeping law to protect patients from unexpected out-of-network medical bills. In their latest post for the Commonwealth Fund, CHIR’s Jack Hoadley and Kevin Lucia review the new rules and their implications for consumers.
For June’s monthly roundup of health policy research, Nia Gooding reviewed studies on ground ambulance rides and surprise medical bills, the ways health plan pricing mechanisms affect health disparities, and the impact of using auto-enrollment to achieve universal coverage.
Starting July 1, those who faced a job loss in 2021 may be eligible for extra financial assistance on the marketplace. CHIR’s Megan Houston breaks down this provision of the American Rescue Plan and how consumers can access these benefits.
When Congress enacted the “No Surprises Act” last year to ban unexpected out-of-network medical bills, it was left to the Biden administration to implement these historic consumer protections. CHIR’s Katie Keith, Jack Hoadley, and Kevin Lucia provide a detailed summary of the first round of federal rules flowing from this new law in their latest post for the Health Affairs blog.
The Biden administration has released its first major set of proposed rules governing the Affordable Care Act marketplaces. In her latest Expert Perspective for the State Health & Value Strategies project, CHIR’s Sabrina Corlette assesses the implications for state-based marketplaces and insurance regulators.
Several states ask for – and publicly post – health insurers’ proposed 2022 premium rates in May and June. These early rate filings can provide hints about how insurers are responding to market trends, policy changes, and emerging drivers of health care costs. CHIR’s Sabrina Corlette took a deep dive into insurers’ actuarial memos to find out how they’re thinking about health care spending after COVID-19, the American Rescue Plan, and more.
During the COVID-19 pandemic, many states temporarily lowered barriers to using telemedicine for health care services. Subsequently, a number of states have taken action to make those changes permanent. In their latest report for the Commonwealth Fund, CHIR experts examine this emerging body of state law and its potential impact on the use of health care services, costs, and outcomes.
Washington State enacted a first-of-its-kind public option, with the state-procured plans available beginning in 2020. But the inaugural year yielded underwhelming results, with fewer than 2,000 people enrolled in the plans and premiums that were on average higher than the prior year’s rates. After identifying several barriers to the program’s success, Washington enacted legislation this year to bolster the state’s public option.
The opinions expressed here are solely those of the individual blog post authors and do not represent the views of Georgetown University, the Center on Health Insurance Reforms, any organization that the author is affiliated with, or the opinions of any other author who publishes on this blog.
